These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25198066)

  • 21. Cell type- and stage-specific expression of Otx2 is regulated by multiple transcription factors and
    Chan CSY; Lonfat N; Zhao R; Davis AE; Li L; Wu MR; Lin CH; Ji Z; Cepko CL; Wang S
    Development; 2020 Jul; 147(14):. PubMed ID: 32631829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
    Andolfo I; Liguori L; De Antonellis P; Cusanelli E; Marinaro F; Pistollato F; Garzia L; De Vita G; Petrosino G; Accordi B; Migliorati R; Basso G; Iolascon A; Cinalli G; Zollo M
    Neuro Oncol; 2012 May; 14(5):596-612. PubMed ID: 22411914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray discovery of new OGT substrates: the medulloblastoma oncogene OTX2 is O-GlcNAcylated.
    Ortiz-Meoz RF; Merbl Y; Kirschner MW; Walker S
    J Am Chem Soc; 2014 Apr; 136(13):4845-8. PubMed ID: 24580054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
    Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC
    Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site.
    Reinisalo M; Putula J; Mannermaa E; Urtti A; Honkakoski P
    Mol Vis; 2012; 18():38-54. PubMed ID: 22259223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.
    Schmidt C; Cohen S; Gudenas BL; Husain S; Carlson A; Westelman S; Wang L; Phillips JJ; Northcott PA; Weiss WA; Schwer B
    Sci Rep; 2024 Jul; 14(1):16074. PubMed ID: 38992221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatin Immunoprecipitation Assays on Medulloblastoma Cell Line DAOY.
    Dobson T; Swaminathan J
    Methods Mol Biol; 2022; 2423():39-50. PubMed ID: 34978686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.
    Shi JA; Lu DL; Huang X; Tan W
    Int J Mol Med; 2014 Jul; 34(1):237-43. PubMed ID: 24756834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes.
    Li Z; Wei Y; Shao Y; Tang L; Gong J
    Brain Tumor Pathol; 2021 Jul; 38(3):234-242. PubMed ID: 34180021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
    Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
    Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active medulloblastoma enhancers reveal subgroup-specific cellular origins.
    Lin CY; Erkek S; Tong Y; Yin L; Federation AJ; Zapatka M; Haldipur P; Kawauchi D; Risch T; Warnatz HJ; Worst BC; Ju B; Orr BA; Zeid R; Polaski DR; Segura-Wang M; Waszak SM; Jones DT; Kool M; Hovestadt V; Buchhalter I; Sieber L; Johann P; Chavez L; Gröschel S; Ryzhova M; Korshunov A; Chen W; Chizhikov VV; Millen KJ; Amstislavskiy V; Lehrach H; Yaspo ML; Eils R; Lichter P; Korbel JO; Pfister SM; Bradner JE; Northcott PA
    Nature; 2016 Feb; 530(7588):57-62. PubMed ID: 26814967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells.
    Wortham M; Jin G; Sun JL; Bigner DD; He Y; Yan H
    PLoS One; 2012; 7(4):e36211. PubMed ID: 22558385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
    Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
    Wiencke JK; Zheng S; Morrison Z; Yeh RF
    Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
    de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Shi X; Wang Q; Gu J; Xuan Z; Wu JI
    Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-Cell Chromatin Accessibility Analysis Reveals Subgroup-Specific TF-NTR Regulatory Circuits in Medulloblastoma.
    Gao X; Zhuang Q; Li Y; Li G; Huang Z; Chen S; Sun S; Yang H; Jiang L; Mao Y
    Adv Sci (Weinh); 2024 Aug; 11(30):e2309554. PubMed ID: 38884167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
    Ferrucci V; de Antonellis P; Pennino FP; Asadzadeh F; Virgilio A; Montanaro D; Galeone A; Boffa I; Pisano I; Scognamiglio I; Navas L; Diana D; Pedone E; Gargiulo S; Gramanzini M; Brunetti A; Danielson L; Carotenuto M; Liguori L; Verrico A; Quaglietta L; Errico ME; Del Monaco V; D'Argenio V; Tirone F; Mastronuzzi A; Donofrio V; Giangaspero F; Picard D; Remke M; Garzia L; Daniels C; Delattre O; Swartling FJ; Weiss WA; Salvatore F; Fattorusso R; Chesler L; Taylor MD; Cinalli G; Zollo M
    Brain; 2018 May; 141(5):1300-1319. PubMed ID: 29490009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
    Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
    Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.